Navigation Links
PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial
Date:3/10/2008

sis has been granted Fast Track designation and orphan drug status in the United States by the FDA and orphan drug designation in Europe by the European Medicines Agency (EMEA).

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufacturers the award winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI's Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDIs). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at http://www.Pari.com


'/>"/>
SOURCE PARI Respiratory Equipment, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,presented data at the ...es,in Cancer in Washington, D.C., announcing the d... that demonstrate significant anticancer,activity ...molecular scaffold has been developed using,comput...3 kinase inhibitors,as well as isoform-selective s...
(Date:8/26/2008)...FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today a...,from the CUSTOM II trial was published in the mos...ntervention. The lead author of the article was,Dr...nter Utrecht, Utrecht,The Netherlands on behalf o...es across Europe., The one-year CUSTOM II trial, ...
(Date:8/25/2008)...nt Strategies--, PHILADELPHIA, Aug. 25 /PRNewswir...utations that are the main cause of the inherited ...addition, the researchers found,that the same muta...f,non-inherited neuroblastoma, the more common for...offer the first genetic tests to families,affected...
(Date:8/25/2008)...d Japanese Development Studies ...25 /- Genmab has,announced ...ic lymphocytic,leukemia and non-Hodgkin,s lymphoma... begin four studies of,ofatumumab in chronic lymph... lymphoma (NHL) this year., "Genmab and GSK have ...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Study finds no connection between vitamin D and overall cancer deaths 5032 1Study finds no connection between vitamin D and overall cancer deaths 5032 2Going live with click chemistry 1040 1Going live with click chemistry 1040 2Going live with click chemistry 1040 3Could hairy roots become biofactories 3F 1036 1Could hairy roots become biofactories 3F 1036 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 1Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 3
... data From 741-patient Trial Show Those Treated wi...mpact on Blood Pressure Compared,to Ibuprofen, EAS...ients with,osteoarthritis who also have controlled...rage daily blood pressure when treated with,the in...b compared,to a slight increase in those taking ib...
... Data to be Presented at the European League Again...tential Benefit of ofatumumab,in Patients With Rhe...Pennsylvania and COPENHAGEN,Denmark, June 15, 200...and Genmab A/S (CSE: GEN) announced today positive...be presented at EULAR,2007, the Annual European Co...
Other Medicine Technology:Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...nataka is planning to enact legislation to make HI...d for politicians seeking to enter the state legis...ment on the need to bring in such a legislation wi...R. Ashok told IANS. Karnataka is one of six high-p...
...ers Novartis, is filing a petition against a court... its anti-cancer drugs. // What makes this news si...uality of life for an AIDS patient; a nightmare or... is backing its right to patent a modified version...
...en who wear a special kind of no-line bifocal lens... those who wear more conventional lenses according...ssue of Investigative Ophthalmology & Visual Scien...ng children with two myopic parents, myopia progre...
...al study led by Johns Hopkins suggests that the ra...haran Africa that HIV dementia along with Alzheime...ng the most common forms of dementia in the world....n the African continent using rigorous neurologica...
Other Medicine News:Health News:HIV Tests to Be Made Mandatory for Karnataka Couples, Politicians 2Health News:To Patent or Not-A Question of Life 2Health News:HIV Dementia Alarmingly High in Africa 2
LabWeb is a full-featured laboratory information system (LIS) with the added benefits only Psyche Systems can deliver - high ROI, a secure hosted offering and a true partnership. LabWeb features adva
LabPak POL Plus 2 Laboratory Information System
...e surgeon to view the patient, c-arm image intensi...ile field. , ,Electrocautery Cord and suction Tub...ng longer cord length sterility. , ,Extra large f...mmodates the larger incise area and can improve as...
...ealth will change the way you think about drapes a...and reduced reimbursements mean costs must be care... the quality of care or jeopardizing patient outco...pective of total value and long-term implications....
Medicine Products: